Dr. David Minor completed his medical school at the University of California, San Francisco. He did his residency in internal medicine at the California Pacific Medical Center-California Campus. He also completed a fellowship in medical oncology at the Yale-New Haven Hospital. He is a board-certified oncologist licensed to practice in the State of California. Dr. Minor has been in clinical practice for 20 years and is currently affiliated with the Saint Francis Memorial Hospital. He has also contributed to over 25 research publications.
University of California San Francisco
California Pacific Medical Center - California Campus
Yale-New Haven Hospital
American Board of Internal Medicine - Oncology
Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma.
Ascierto, P. A.,Minor, D.,Ribas, A.,Lebbe, C.,O'Hagan, A.,Arya, N.,Guckert, M.,Schadendorf, D.,Kefford, R. F.,Grob, J. J.,Hamid, O.,Amaravadi, R.,Simeone, E.,Wilhelm, ...; J. Clin. Oncol.. 2013 Sep 10.See more >>
Lymphocytic vasculitis of the uterus in a patient with melanoma receiving ipilimumab.
Minor, D. R.,Bunker, S. R.,Doyle, J.; J. Clin. Oncol.. 2013 Jul 10.See more >>
Inoperable bulky melanoma responds to neoadjuvant therapy with vemurafenib.
Fadaki, N., Cardona-Huerta, S., Martineau, L., Thummala, S., Cheng, S. T., Bunker, S. R., Garcia-Kennedy, R., Wang, W., Minor, D., Kashani-Sabet, M., Leong, S. P.; BMJ Case Rep. 2012.See more >>